Health News Releases

  • Today July 1
May 07, 2024 11:30
Parse Biosciences Launches Single Cell Immune Profiling Products
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ BCR and the expansion of its existing Evercode™ TCR pro
May 03, 2024 10:35
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 bi
WHOOP announces significant global expansion, appoints new senior leadership. Continues “Free Trials
May 01, 2024 12:55
WHOOP Announces Significant Global Expansion, Appoints New Senior Leadership
WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2F&esheet=53961244&newsitemid=20240429085870&lan=en-US&anchor=WHOOP&index=1&md5=208ea6634cca605d44e019265ce45daf)
April 28, 2024 13:10
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended
April 28, 2024 11:40
CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
Please replace the release dated April 26, 2024 with the following corrected version due to multiple revisions. The updated release reads: RENAGADE THERAPEUTICS CONTINUES COMMITMENT TO GANNA BIO
April 25, 2024 17:05
Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers
Last week Exergen Corporation filed a lawsuit against Baxter International Inc. in the United States District Court for the District of Massachusetts. As detailed in its complaint, Exergen’s lawsuit i
April 25, 2024 14:55
Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation provi
April 24, 2024 14:34
Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth
Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024. · Record net sales of 1.071 billion USD in the first qu
Rubedo Life Sciences scientists (Photo: Business Wire)
April 24, 2024 10:10
Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging
Rubedo Life Sciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rubedolife.com%2F&esheet=53939040&newsitemid=20240423657886&lan=en-US&anchor=Rubedo+Life+Sciences&index=1&md
April 24, 2024 09:30
ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced an oral and poster presentation highlighting preclinical data supporting its comprehensive RNA tec
April 23, 2024 16:50
AI Medical Service Inc. Signs Joint Research Agreement with Mahidol University in Thailand
AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, signed a joint research agreement with Mahidol University in Thailand (herein
High power UV-C LED (Graphic: Business Wire)
April 23, 2024 15:45
Toyoda Gosei Develops UV-C LED with World-Class Light Output
Toyoda Gosei Co., Ltd. (TOKYO:7282) has developed deep ultraviolet (UV-C) LEDs with light output that is among the highest in the world.[1] UV-C is used in disinfection as it destroys viral and bacter
April 23, 2024 09:45
Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital
Rubedo Life Sciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rubedolife.com%2F&esheet=53939039&newsitemid=20240422384739&lan=en-US&anchor=Rubedo+Life+Sciences&index=1&md
Learn more about the economic benefits of investing in adult immunisation programmes in a new study
April 18, 2024 15:40
The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
A new report published today reveals that adult vaccination programmes can return up to 19 times their initial investment when the full spectrum of economic and societal benefits is valued. The 19x re
April 18, 2024 14:15
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
Masimo (https://www.masimo.com/en-us/) (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6th Global Ministerial Summit on Patien
April 18, 2024 08:00
INB Korea Ltd removes the bubble of the price on air sterilizer, cutting the price by 70% , NEW ‘UPPERVIOLET ODEO’ product is launched
INB Korea Ltd, the manufacturer of ‘viruskiller’, a K- air purifier and sterilizer product in Korea that exported 20 million dollar to 53 countries during the COVID19 outbreak, announced on the 17th o
Left to right: Tony Dos Santos, Founder | Maria Zaccardo, Co-founder | Sanjay D. Goorachurn, CEO (Ph
April 17, 2024 09:57
A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer
Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony Dos Santos a
April 17, 2024 09:15
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clin
JB Agnus, Chief Business Officer, KBI Biopharma, Inc. (Photo: Business Wire)
April 16, 2024 11:40
KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief
April 12, 2024 15:00
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.
ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed. This acquisition further enhances the vertical integration of Telix’s supply
April 09, 2024 14:28
Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring
Ferring today published its 2023 Annual Report (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ferring.com%2Fwp-content%2Fuploads%2Fsites%2F16%2F2024%2F04%2FFerring-Pharmaceutic
April 09, 2024 13:19
Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=53923546&newsitemid=20240408059362&lan=en-US&anchor=TSE%3A4502%2FNYSE%
April 09, 2024 12:05
AACR 2024: PDC*line Pharma Presents Interim Clinical Results From Last Cohort of Patients in Phase I/II Trial with PDC*lung01 Cancer Vaccine
PDC*line Pharma, a clinical-stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the interim results from the last cohort of patients
April 09, 2024 11:30
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the phase 3 comparative clinical trial for the investigational Prolia® and Xgeva® (denosumab) biosimilar HLX14 met the p
April 04, 2024 15:10
Panda Biotech Announces Commercial Operations Have Begun at Its Flagship Panda Hemp Gin
Panda Biotech™ announced today that commercial operations have officially begun at the Panda Hemp Gin, their landmark industrial hemp processing facility in Wichita Falls, Texas. The 500000-square-foo
25 per page50 per page75 per page100 per page